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The short-chain dehydrogenase enzymes WbmF, WbmG and WbmH from
Bordetella bronchiseptica were cloned into Escherichia coli expression vectors,
overexpressed and purified to homogeneity. Crystals of all three wild-type
enzymes were obtained using vapour-diffusion crystallization with high-
molecular-weight PEGs as a primary precipitant at alkaline pH. Some of the
crystallization conditions permitted the soaking of crystals with cofactors and
nucleotides or nucleotide sugars, which are possible substrate compounds, and
further conditions provided co-complexes of two of the proteins with these
compounds. The crystals diffracted to resolutions of between 1.50 and 2.40 A˚ at
synchrotron X-ray sources. The synchrotron data obtained were sufficient to
determine eight structures of the three enzymes in complex with a variety of
cofactors and substrate molecules.
1. Introduction
The Bordetella species B. parapertussis and B. bronchiseptica are
widely studied pathogens that infect the respiratory tracts of
mammals. B. parapertussis is associated with approximately 5% of
cases of whooping cough in humans (Cherry, 1996) and a separate
lineage causes respiratory infections in sheep (Porter et al., 1994).
B. bronchiseptica has a broad host range and is a cause of kennel
cough (Burns et al., 1993) and atrophic rhinitis (Magyar et al., 1988) in
dogs and pigs, respectively. Lipopolysaccharide (LPS), the major
component of the outer leaflet of the outer membrane, is one of the
virulence factors implicated in infections by these bacteria. B. para-
pertussis and B. bronchiseptica are closely related and LPS in both
species is substituted with an O antigen, which elicits a strong
immunological response in infected animals and protects against
complement-mediated killing in vitro (Burns et al., 2003).
The synthesis of the O antigen has been localized to a single
genetic locus in these bacteria, the wbm locus (Preston et al., 1999).
This locus contains 24 genes, many of which are similar to the O-
antigen synthesis genes described in other bacteria. Based on the
homology of the genes in the wbm locus to proteins of known
function and on the activities required to produce the sugar residues
found in the mature O antigen, we have devised a path to the
synthesis of each component of this structure and are in the process
of verifying various steps (JDK, AP and DJM, unpublished obser-
vations). However, some of the steps cannot be unambiguously
assigned to a single gene product. In particular, genome sequencing
has revealed that the wbm locus contains three neighbouring genes
(wbmF, wbmG and wbmH) with homology to the widespread short-
chain dehydrogenase/reductase (SDR) gene family that are proposed
to carry out the epimerization of UDP-ManNAcNAcAN at the
30 and 50 positions. This reaction requires three distinct activities
(40-oxidation, 30,50-epimerization and 40-reduction). All of these
activities can be carried out by SDR enzymes and indeed a single
enzyme capable of catalysing all three activities with an analogous
sugar-nucleotide substrate has been described (Major et al., 2005).
However, there are many examples where multiple enzymes are
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required to carry out the 30,50-epimerization (Ginsburg, 1960, 1961;
Tonetti et al., 1998; Giraud & Naismith, 2000).
Genetic studies of wbmF, wbmG and wbmH have supported a role
for each of these genes in synthesis of the O antigen (King et al.,
2007), but could not distinguish unambiguous roles for any one of the
encoded enzymes. In addition, since SDR enzymes tend to have low
sequence identities to one another (typically 15–30% identity to the
nearest non-orthologue), it is not possible to predict the likely activity
of these enzymes from their sequences.
Structural analysis of these enzymes should allow the identification
of the amino acids that are associated with the active site in each
enzyme and provide a clearer view of the probable catalytic activities
of each. In addition to unravelling the molecular basis of the synthesis
of the O antigen in these pathogens, the structural analysis should
also prove a test of the idea that structural studies can be used to
determine the function of proteins of known class but unknown
activity.
2. Cloning, expression and purification of WbmF, WbmG and
WbmH
The full-length coding sequences of WbmF (GeneID 2660132),
WbmG (GeneID 2662020) and WbmH (GeneID 2660170) were
inserted into pET15b (Novagen) using the NdeI (NEB) and BamHI
restriction sites. B. bronchiseptica chromosomal DNA was prepared
by suspending a single bacterial colony in 500 ml water and incubating
in boiling water for 5 min. The resulting suspension was centrifuged
at 14 500g for 2 min and the supernatant was used as a template for
the PCR reaction. PCR primers were designed to introduce an NdeI
site including the native start codon and a BglII site after the stop
codon. The resulting expression constructs contain a 6His tag, a
thrombin cleavage site and the full-length coding sequence of the
relevant enzyme. The 6His tag was not removed during purification,
resulting in an N-terminal cloning artefact sequence of MGSSH-
HHHHHSSGLVPRGSH in all three proteins. Including these resi-
dues, the final constructs encoded proteins that contained 377, 330
and 333 amino acids and had expected molecular weights of 41 536,
35 247 and 36 586 Da for WbmF, WbmG and WbmH, respectively.
The expression constructs were transformed into BL21 (DE3) cells
(Novagen) and grown in 2YT medium supplemented with
100 mg ml1 carbenicillin at 310 K. When the optical density of the
medium at 600 nm reached 0.5, expression of the protein was induced
by the addition of 0.4 mM IPTG and the cells were grown for 5 h at
288 K. The cells were harvested by centrifugation and resuspended in
25 ml resuspension buffer (20 mM Tris–HCl pH 8.0, 0.5M NaCl
supplemented with one tablet per 50 ml of Complete EDTA-free
protease inhibitors; Roche) per litre of culture.
The bacterial cells were lysed by sonication (XL sonicator,
Misonix) and clarified by centrifugation at 21 000g for 20 min,
followed by 0.22 mm filtration of the supernatant. WbmF, WbmG and
WbmH were purified by nickel-affinity chromatography using a 1 ml
HisTrap HP column (GEHealthcare): the column was equilibrated in
lysis buffer (without protease inhibitors) and charged with clarified
lysate (from 1 l expression volume). Following binding, the column
was washed thoroughly with 20 mM Tris–HCl pH 8.0, 0.5M NaCl,
5 mM imidazole and the target protein was eluted using a gradient to
125 mM imidazole over 20 column volumes. Following this, the
protein was purified by size-exclusion chromatography using a
Superdex 75 26/60 column (GE Healthcare) with an elution buffer of
20 mM Tris–HCl pH 8.0, 150 mM NaCl and a flow rate of 1 ml min1.
The typical yield from 1 l expression was 35 mg purified protein. The
purified protein was then concentrated using VivaSpin columns
(Vivascience) with a molecular-weight cutoff of 10 kDa to an
appropriate concentration in the size-exclusion elution buffer. The
protein was subsequently crystallized in this buffer. In the case of
WbmF, the chromatography steps were both completed within 8 h of
cell lysis; NAD+ or NADH was added to the sample to a concen-
tration of 1 mM immediately following elution from the size-
exclusion chromatography column and the protein was concentrated
with cofactor present. These steps significantly improved the yield
and stability of the purified protein and crystallization was not
successful using material to which cofactor had not been added.
Selenomethionine-labelled WbmG was prepared using the method
of Van Duyne et al. (1993). The yield was slightly lower than that of
nonlabelled material. Mass spectrometry indicated that the extent of
labelling was >95% (data not shown).
3. Crystallization of WbmF, WbmG and WbmH
Initial crystallization screening of each protein and of cocrystals of
WbmF and WbmG with UDP was carried out using sitting-drop
vapour diffusion at 293 K. Each protein was screened using mother
liquors from Crystal Screens 1 and 2 (Hampton Research) and from
either the Wizard I and II crystallization screens (Emerald Bio-
structures; protein with cofactors) or from the broadly equivalent
SM1 screen (Qiagen; protein–UDP cocrystals). For each crystal-
lization condition, 100 ml mother liquor was added to a reservoir in a
96-well CrystalQuick crystallization plate with square sitting-drop
positions (Molecular Dimensions). Three sitting drops were estab-
lished in the shelves adjacent to the reservoir using a Honeybee 81
crystallization robot (Genomic Solutions). Each sitting drop
crystallization communications
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Figure 1
Representative crystals of WbmF, WbmG and WbmH: representative crystals of
the major crystal forms used in this study are shown. (a) Crystal of WbmF after
approximately 10 d growth. The conic hollows in the crystals were characteristic of
this crystal from. (b) Crystals of WbmG after approximately 12 d growth. (c) The
one diffraction-quality crystal of WbmH that was grown, pictured at the end of its
growth. The scale bar corresponds to 100 mm in (a) and (b) and 10 mm in (c).
contained 100 nl mother liquor and 100 nl protein solution. A sepa-
rate plate was used for each protein; each experiment tested two
concentrations of each protein (7 and 14 mg ml1 for WbmF, 8 and
16 mg ml1 for WbmG and 5 and 10 mg ml1 for WbmH), with a
buffer control in the third position. Conditions that yielded crystals
were optimized with manually prepared conditions using 24-well
Linbro plates and glass cover slides (Hampton Research).
Diffraction-quality crystals of WbmF were optimized from Wizard
I conditions 1 and 21 and the Wizard II conditions 3 and 24. Crystals
(in complex with NAD+ or NADH) were grown using hanging-drop
vapour diffusion at 293 K over a 500 ml reservoir containing
16%(w/w) PEG 8000, 0.1M Bicine pH 9.0. Each drop contained 2 ml
WbmFat 14 mg ml1, with NAD+ or NADH at 1 mM and 2 ml mother
liquor. Diffraction-quality crystals grew in 3 d, reaching dimensions
of 0.3  0.1  0.1 mm (Fig. 1a).
Diffraction-quality crystals of WbmG were optimized fromWizard
II condition 3. Crystals were grown using hanging-drop vapour
diffusion at 293 K over a 500 ml reservoir containing 16–18%(w/w)
PEG 8000, 0.1M Tris–HCl pH 8.5, 0.2MMgCl2. Each drop contained
1.5 ml WbmG (16 mg ml1) and 1.5 ml mother liquor. Crystals grew
rapidly and after 7 d good-quality crystals had reached dimensions of
50  30  30 mm (Fig. 1b). Similar crystals of selenomethionine-
labelled WbmG grew under identical conditions.
One diffraction-quality crystal of WbmH was found in the initial
sparse-matrix screen in Crystal Screen I, condition 41, using
5 mg ml1 WbmH. The mother liquor contained 10%(v/v)
2-propanol, 20%(w/v) PEG 4000, 0.1M HEPES pH 7.5. The crystal
grew over 11 d and reached dimensions of 30  10 10 mm (Fig. 1c).
Subsequent attempts to optimize this condition did not provide
crystals of the same quality and this crystal proved sufficient to solve
the structure to a good resolution.
Crystals of WbmF and WbmG were soaked with nucleotides or
nucleotide sugars by preparing an artificial mother liquor containing
16%(w/w) PEG 8000, 0.1M Bicine pH 9.0 (for WbmF) or 16%(w/w)
PEG 8000, 0.1M Tris–HCl pH 8.5, 0.2M MgCl2 (for WbmG)
supplemented with 10 mM nucleotide or sugar nucleotide. Crystals
were incubated in this mother liquor for 5–30 min and then trans-
ferred to cryocooling solution. The cryocooling solution used for
WbmF crystals was 16%(w/w) PEG 8000, 0.1M Bicine pH 9.0,
20%(v/v) PEG 400; for WbmG, 16%(w/w) PEG 8000, 0.1M Tris–HCl
pH 8.5, 20%(v/v) PEG 400 was used as the cryocooling solution. The
crystals showed no sign of damage after incubation in this solution for
1 min. The WbmH crystal was transferred to a cryocooling solution
consisting of 8.5% 2-propanol, 17%(w/v) PEG 4000, 15% glycerol,
0.085M HEPES pH 7.5 before cooling in liquid nitrogen.
A second crystal form of WbmF was obtained by cocrystallizing
WbmF with NAD+ and 10 mM UDP. One diffraction-quality crystal
was found in the initial sparse-matrix screen in SM1 screen condition
59, using 14 mg ml1 WbmF. The mother liquor contained 20%(w/v)
PEG 3000, 0.1M Tris pH 7.0, 0.2M calcium acetate. The crystal grew
in 7 d and reached dimensions of 100  100  50 mm. Attempts to
reproduce the crystal were unsuccessful and this crystal provided data
to an excellent resolution. The crystal was transferred to a cryo-
protectant solution consisting of 24%(w/v) PEG 3000, 80 mM Tris pH
7.0, 160 mM calcium chloride and 20%(v/v) glycerol.
A second crystal form was obtained by cocrystallizing WbmG with
10 mMUDP. Diffraction-quality crystals were optimized from Crystal
Screen I condition 39. The mother liquor contained 1.6M ammonium
sulfate, 2%(v/v) PEG 400, 0.1M HEPES pH 7.5, 10 mM UDP. Each
drop contained 2 ml WbmG solution (16 mg ml1) and 2 ml mother
liquor. Crystals grew in 11 d to dimensions of approximately 100 50
 50 mm. Crystals were transferred to a cryocooling solution
consisting of 1.6M ammonium sulfate, 2%(v/v) PEG 400, 0.1M
HEPES pH 7.5, 15%(v/v) glycerol.
4. X-ray analysis
4.1. X-ray data collection of WbmF crystals
High-resolution data sets for WbmF crystals were obtained at
100 K at beamline ID14-4 at ESRF (Grenoble, France). Data were
collected over 200 with 1 oscillation per image on an ADSC
Quantum-315 detector (Fig. 2). One crystal (WbmF in complex with
NADH) gave particularly strong diffraction and so a second data set
covering the same oscillation range was collected using strong
attenuation to ensure that a complete data set was collected at low
resolution.
crystallization communications
Acta Cryst. (2007). F63, 711–715 Harmer et al.  Short-chain dehydrogenases 713
Figure 2
Representative images from the data collection for the apo forms of WbmF, WbmG (GDP-mannose soak) and WbmH are shown. Each image corresponds to the first image
collected at the synchrotron source. Inset are closer views of the same image at the resolution edge, with the contrast reset to highlight visible spots at the edge, marked by
arrows. (a) WbmF in complex with NADH; the arrowed spots both correspond to 1.50 A˚. (b) WbmG soaked with GDP-mannose; the arrowed spots correspond to 2.10 A˚
(left) and 2.08 A˚ (right). (c) WbmH; the arrowed spots correspond to 2.20 A˚ (left) and 2.15 A˚ (right). The resolution edges after integration and scaling were chosen at 1.50,
2.10 and 2.20 A˚, respectively.
4.2. X-ray data collection of WbmG crystals
High-resolution data sets from these crystals were obtained at
100 K. Data for WbmG soaked with GDP-mannose (Fig. 2), WbmG
soaked with UDP-glucose and selenomethionine-labelled WbmG
were collected at beamline PX14.2 at the Daresbury SRS (Daresbury,
UK). Data were collected over 200 with 1 oscillation per image on
an ADSC Quantum-100 detector, except for the MAD data, where
data were collected at peak (720), inflection (720) and remote
wavelengths (360). Data for WbmG cocrystallized with UDP were
collected at beamline ID14-4 at ESRF (Grenoble, France). Data were
collected at 100 K over 110 with oscillations of 0.2–1 per image on
an ADSC Quantum-100 detector. Appropriate oscillation angles for
avoiding overlaps were determined using MOSFLM (Leslie, 1992).
4.3. X-ray data collection of the WbmH crystal
A high-resolution data set from this crystal was obtained at 100 K.
Data were collected at station ID29 at ESRF (Grenoble, France).
Data were collected over 90 with 0.5 oscillation per image on an
ADSCQuantum-315 detector (Fig. 2). Subsequently, a low-resolution
data set was collected at the Daresbury SRS (Daresbury, UK). Data
were collected over 180 with 1 oscillation per image on an ADSC
Quantum-100 detector.
4.4. Processing of X-ray data
The data were processed using DENZO and scaled using
SCALEPACK (Otwinowski & Minor, 1997). The space groups
determined, the unit-cell parameters and the crystallographic data
are summarized in Table 1. Based on the packing densities
(Matthews, 1968; Collaborative Computational Project, Number 4,
1994) and solvent contents of the crystals with the expected number
of protein molecules in the asymmetric unit (full details in Table 1),
WbmF is likely to have one molecule per asymmetric unit. The crystal
form obtained for cocrystals of WbmF with UDP is likely to have two
molecules per asymmetric unit, as this leads to a packing density
almost identical to that of the previous crystal form. ForWbmG in the
C2 crystal form, two monomers per asymmetric unit are the most
likely. The C2221 crystal form also has an acceptable packing density
with two monomers in the asymmetric unit. For WbmH, it is most
likely that the unit cell contains three monomers per asymmetric unit;
however, either two or four monomers per asymmetric unit would
correspond to precedented values for the packing density and solvent
content.
Three previously solved protein structures have similar homology
to WbmF (PDB codes 1bxk, 1keu and 1r6d). Each of these proteins
has 26–27% sequence identity to WbmF. These three proteins, with
nonhomologous side chains truncated to C, were used as molecular-
replacement probes. Molecular replacement using Phaser (McCoy et
al., 2005) and MOLREP (Vagin & Teplyakov, 1997) gave identical
solutions. Following density modification with DM (Cowtan, 1994),
the electron density became interpretable and permitted structure
solution. The refined structure of WbmF (King et al., 2007) was used
as a molecular-replacement probe for the second crystal form.
Molecular replacement using Phaser, with a crystallographic dimer of
WbmF as the model, provided a successful solution.
Although there is a previously solved structure of a homologue of
WbmG with a sequence identity of 28% (PDB code 1r66), molecular
replacement proved unsuccessful; solutions with seemingly excellent
correlations to the data could not be refined (data not shown). A self-
rotation function was calculated for the C2 crystal form and this
revealed that there was a noncrystallographic twofold rotation axis
between the two molecules in the asymmetric unit, which was closely
aligned with the crystallographic twofold rotation axis. It seemed
likely that the alignment of the two axes made molecular replacement
impossible. Therefore, we prepared selenomethionine-labelled
protein and obtained diffraction data from labelled WbmG (Table 2).
Analysis of this data using SOLVE (Terwilliger & Berendzen, 1999)
demonstrated that eight of the ten potential selenium sites could be
convincingly found at full occupancy, indicating that the structure
could be solved from this data.
Following the solution of the structure of WbmG, structure solu-
tion of WbmH using molecular replacement was attempted. WbmG
shows 40% sequence identity to WbmH, whereas no other protein
crystallization communications
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Table 1
Data-collection statistics for native data sets.
Values in parentheses are for the highest resolution shell.
WbmF–NAD+ WbmF–NADH
WbmF–NAD+–
UDP soak
WbmF–NAD+–
UDP cocrystal
WbmG–GDP–
Man soak
WbmG–UDP–
Glc soak
WbmG–UDP
cocrystal WbmH
Space group C2 C2 C2 C2 C2 C2 C2221 P21212
Unit-cell parameters
a (A˚) 82.88 83.19 83.44 121.85 192.04 191.23 58.21 93.67
b (A˚) 77.88 77.86 78.12 79.68 49.76 49.79 140.48 158.99
c (A˚) 59.23 59.41 59.26 84.95 76.02 75.91 184.14 68.22
 () 90 90 90 90 90 90 90 90
 () 108.17 108.19 108.08 113.10 101.13 101.12 90 90
 () 90 90 90 90 90 90 90 90
Matthews coefficient
(A˚3 Da1)
2.16 2.17 2.16 2.23 2.49 2.45 2.60 2.28
Solvent content (%) 43.1 43.4 43.1 45.0 50.6 49.8 52.7 46.1
Unit-cell volume (A˚3) 363220 365646 367220 758697 712807 769223 1505882 1016022
Molecules per ASU 1 1 1 2 2 2 2 3
Molecules per unit cell 4 4 4 8 8 8 16 12
Unique reflections 27275 57271 33895 81311 38661 27549 51158 49975
Resolution range 50–1.90 (1.93–1.90) 50–1.5 (1.53–1.50) 50–1.75 (1.78–1.75) 50–1.7 (1.73–1.70) 30–2.1 (2.15–2.1) 30–2.4 (2.46–2.40) 30–2.0 (2.03–2.00) 30–2.2 (2.25–2.2)
Completeness (%) 96.6 (77.4) 99.3 (94.8) 93.3 (62.6) 98.4 (87.1) 97.6 (79.2) 98.7 (97.7) 99.9 (100) 93.9 (91.3)
Redundancy 4.6 (3.0) 4.8 (3.7) 3.9 (2.4) 3.9 (2.9) 3.83 (3.08) 4.47 (4.45) 5.9 (5.9) 5.22 (3.58)
Rmerge† 3.9 (22.3) 5.2 (65.8) 4.9 (33.7) 5.5 (45.9) 7.5 (48.3) 10.3 (32.8) 8.5 (77.3) 11.4 (38.0)
hI/(I)i 32.1 (5.89) 29.5 (1.83) 23.7 (2.38) 21.9 (2.18) 16.9 (2.14) 15.0 (3.98) 19.6 (2.28) 15.2 (3.63)
Data-collection
wavelength (A˚)
0.977 0.977 0.977 0.977 1.488 1.488 0.977 0.9340/1.488
PDB code 2pzj 2q1s 2q1t 2q1u 2pzk 2pzl 2pzm 2q1w
† Rmerge =
P
h
P
l jIhl  hIhij=
P
h
P
lhIhi, where Il is the lth observation of reflection h and hIhi is the weighted average intensity for all observations l of reflection h.
with a solved structure has a sequence identity to WbmH of above
22%. However, attempts to find a solution to the molecular-
replacement problem using Phaser, MOLREP or AMoRe (Navaza,
1994) were unsuccessful using the high-resolution data set. Exam-
ination of the data suggested that the low completeness of the data,
particularly in the lowest resolution shell (completeness only 83%),
might be the cause of the failure to determine the solution. Therefore,
a second data set was collected with a focus on ensuring 100%
completeness in all resolution shells. The crystal showed significant
radiation damage from the collection of the first data set and there-
fore the quality and resolution of the data were considerably poorer
than for the first data set. However, with this complete data set
Phaser was able to determine the correct molecular-replacement
solution, with three molecules in the asymmetric unit. By scaling the
two data sets together, a satisfactory data set with more accurate data
and a higher completeness in the lower resolution shells (>95%) was
obtained and the electron density was clearly interpretable following
molecular replacement.
A full description of the refinement of these structures and their
implications will be reported elsewhere (King et al., 2007).
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Table 2
Data-collection statistics for WbmG MAD data.
Values in parentheses are for the highest resolution shell.
Peak Inflection Remote
Space group C2
Unit-cell parameters a = 190.86, b = 48.91, c = 75.77,  = 90,  = 101.0,  = 90
Wavelength 0.97905 0.97938 0.97668
Resolution (A˚) 30–2.65 (2.71–2.65) 30–2.65 (2.71–2.65) 30–2.65 (2.71–2.65)
Rmerge† 6.9 (24.0) 7.3 (28.9) 7.0 (24.7)
hI/(I)i 41.0 (12.1) 40.4 (10.5) 27.9 (8.47)
Completeness (%) 100 (100) 100 (100) 100 (100)
Redundancy 14.5 (14.8) 14.5 (14.8) 7.27 (6.96)
† Rmerge =
P
h
P
l jIhl  hIhij=
P
h
P
lhIhi, where Il is the lth observation of reflection h
and hIhi is the weighted average intensity for all observations l of reflection h.
